statistiche ricercatore

MORTARA, LORENZO

Distribuzione geografica

Continente	#
NA - Nord America	19.579
EU - Europa	14.952
AS - Asia	7.659
SA - Sud America	829
Continente sconosciuto - Info sul continente non disponibili	348
AF - Africa	151
OC - Oceania	29
AN - Antartide	1
Totale	43.548

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	19.086
IT - Italia	8.667
SG - Singapore	2.498
UA - Ucraina	1.797
CN - Cina	1.713
VN - Vietnam	1.083
HK - Hong Kong	850
TR - Turchia	812
SE - Svezia	724
FR - Francia	699
BR - Brasile	687
DE - Germania	686
FI - Finlandia	615
IE - Irlanda	491
GB - Regno Unito	391
RU - Federazione Russa	281
CA - Canada	225
IN - India	182
BD - Bangladesh	168
NL - Olanda	143
MX - Messico	118
JP - Giappone	95
PL - Polonia	79
ES - Italia	78
AR - Argentina	57
BE - Belgio	49
CH - Svizzera	46
IQ - Iraq	46
AT - Austria	42
ZA - Sudafrica	41
NG - Nigeria	40
CZ - Repubblica Ceca	31
CR - Costa Rica	28
PK - Pakistan	25
ID - Indonesia	24
LT - Lituania	22
CO - Colombia	21
MY - Malesia	21
HN - Honduras	19
EC - Ecuador	18
JM - Giamaica	18
PT - Portogallo	18
AU - Australia	17
IL - Israele	16
AE - Emirati Arabi Uniti	15
UZ - Uzbekistan	15
CL - Cile	14
EU - Europa	14
SA - Arabia Saudita	14
VE - Venezuela	14
EG - Egitto	13
MA - Marocco	13
PR - Porto Rico	13
SV - El Salvador	13
NZ - Nuova Zelanda	12
RO - Romania	12
MD - Moldavia	11
TT - Trinidad e Tobago	11
GT - Guatemala	10
NO - Norvegia	10
PY - Paraguay	10
GP - Guadalupe	9
KE - Kenya	9
TH - Thailandia	9
DZ - Algeria	8
GR - Grecia	8
PH - Filippine	8
TN - Tunisia	8
BG - Bulgaria	7
JO - Giordania	7
KR - Corea	7
NI - Nicaragua	7
BB - Barbados	6
KZ - Kazakistan	6
NP - Nepal	6
BH - Bahrain	5
DK - Danimarca	5
HU - Ungheria	5
LB - Libano	5
OM - Oman	5
SC - Seychelles	5
SN - Senegal	5
AZ - Azerbaigian	4
BY - Bielorussia	4
DO - Repubblica Dominicana	4
EE - Estonia	4
RS - Serbia	4
IR - Iran	3
LU - Lussemburgo	3
MK - Macedonia	3
PE - Perù	3
PS - Palestinian Territory	3
SK - Slovacchia (Repubblica Slovacca)	3
UY - Uruguay	3
A2 - ???statistics.table.value.countryCode.A2???	2
AL - Albania	2
BA - Bosnia-Erzegovina	2
BF - Burkina Faso	2
BS - Bahamas	2
CG - Congo	2
Totale	43.174

Salva come PNG Salva come JPEG

Città	#
Milan	4.325
San Jose	1.938
Ashburn	1.854
Singapore	1.442
Jacksonville	1.344
Chandler	1.254
Fairfield	1.025
Council Bluffs	935
Hong Kong	829
Woodbridge	773
Ann Arbor	629
Houston	547
Dallas	521
Beijing	493
Princeton	492
Dublin	482
Wilmington	463
Rome	450
Dearborn	421
Izmir	400
The Dalles	386
Nyköping	379
Boardman	363
Seattle	363
Como	343
Cambridge	318
Dong Ket	314
Los Angeles	281
Chicago	258
New York	256
Lauterbourg	251
San Mateo	162
Ho Chi Minh City	160
Santa Clara	151
Hanoi	147
Helsinki	146
São Paulo	107
Munich	104
San Diego	102
Kocaeli	93
London	92
Turin	88
Ogden	84
Orem	78
Tokyo	78
Buffalo	76
Mexico City	74
Guangzhou	71
Varese	65
Naples	63
Turku	60
Warsaw	60
Toronto	59
Florence	57
Montreal	57
Chennai	55
Frankfurt am Main	53
Hefei	52
Verona	51
Phoenix	50
Düsseldorf	49
Atlanta	48
Brooklyn	45
Brussels	43
Manchester	43
Denver	42
Kunming	42
Bologna	41
Washington	41
Nanjing	40
Stockholm	40
Genoa	39
San Francisco	39
Shanghai	35
Boston	33
Jinan	32
Johannesburg	32
Amsterdam	31
Norwalk	31
Salt Lake City	31
Abuja	30
Bari	28
Nuremberg	27
Palermo	26
Poplar	26
Da Nang	25
Pune	25
Hangzhou	24
North Bergen	24
Vienna	24
Berlin	23
Brno	23
Brescia	21
Tianjin	21
Charlotte	20
Fuzhou	20
Querétaro	20
Redmond	20
Des Moines	19
Zhengzhou	19
Totale	27.866

Salva come PNG Salva come JPEG

Nome	#
Allergie e intolleranze. Icone di immunopatologia.	2.747
Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer	328
Polarization of Tumor Infiltrating Leukocytes from Innate Immunity and their role in the Pro-angiogenic Phenotype in NSCLC	322
Natural killer cells from patients with malignant or inflammatory pleural effusions display decreased cytotoxicity and decidual NK-like phenotype	292
Myeloid derived suppressor cells interactions with natural killer cells and pro-angiogenic activities: roles in tumor progression	278
Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?	265
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells	256
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies	250
Can the co-dependence of the immune system and angiogenesis facilitate pharmacological targeting of tumours?	248
DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus SIVagm	242
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment	241
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4(+) T lymphocytes for immunotherapy	240
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response	240
Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization	239
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS	237
Grading of laboratories on CD4+T-lymphocyte evaluations based on acceptable data boundaries defined by the measurement error	235
Natural killer cells from patients with either malignant or inflammatory pleural effusions display decreased cytotoxic capacity and decidual-like phenotype	233
Natural killer cells as key players of tumor progression and angiogenesis: old and novel tools to divert their pro-tumor activities into potent anti-tumor effects	231
Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review	231
The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer	230
Acetyl-L-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways	230
T2 ribonuclease-mediated tumor suppression: an evolutionary conserved process involving a cross-talk between cancer cells and the immune system	230
Analysis of Graves’ disease from the origins to the recent historical evolution	227
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions.	223
Recognition of antigenic clusters of Candida albicans by T lymphocytes from human immunodeficiency virus-infected persons.	219
Positive role of macaque cytotoxic T lymphocytes during SIV infection: decrease of cellular viremia and increase of asymptomatic clinical period.	218
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection and specific anti-tumor memory.	215
The human RNASET2 protein affects the polarization pattern of human macrophages in vitro	215
Microenvironment-mediated regulation of cancer growth by the human RNASET2 oncosuppressor gene	215
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent antitumor preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.	214
Proffered Paper: The pro-angiogenic phenotype of natural killer cells infiltrating squamous cell carcinoma lung cancer	214
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific anti-tumor memory	214
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a TH1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory	213
Orchestration of angiogenesis by immune cells	209
The therapeutic T-cell response induced by tumor delivery of TNF and melphalan is dependent on early triggering of natural killer and dendritic cells	209
Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication	206
Early triggering of natural killer and dendritic cell during antitumor therapeutic response induced by TNFa tumor vessel delivery and melphalan	205
The pro-angiogenic phenotype and functions of colorectal cancer tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells	203
Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors	202
Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.	201
CD56(bright)CD16(-) NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4(+) T Cell Proliferation	200
Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: Implications for immunotherapy	199
Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy	199
Regulation of macrophage differentiation and polarization pattern by human RNASET2 protein	199
Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene	197
The story of a vitamin for bone health that upgraded to hormone for systemic good health.	195
Analysis of the antigen specific T cell repertoire in HIV infection	194
Schedule-dependent therapeutic efficacy of L19mTNF-a and Melphalan combined with Gemcitabine	192
The rnaset2 oncosuppressor protein regulates both differentiation and polarization in human macrophages	192
Selection of virus variants and emergence of virus escape mutants after immunization with epitope vaccine	191
Early DC and NK cell activation during anticancer therapeutic response induced by TNFa tumor vessel delivery and melphalan	191
Tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells: a new paradigm in colorectal cancer angiogenesis	189
Tumor targeted IL-2 and TNF alpha trigger a synergistic T cell-mediated therapeutic effect against mouse neuroblastoma.	188
New strategies of mammary cancer vaccination	187
Biomedicine and traditional Chinese medicine: a fruitful scientific and cultural interaction.	186
Tumor vasculature targeted TNFα therapy: reversion of microenvironment anergy and enhancement of the anti-tumor efficiency.	183
Severità del Morbo di Basedow di prima diagnosi: ruolo dei linfociti Treg e dei micronutrienti. Dati preliminari di uno studio osservazionale pilota	182
The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: a focus on innate immunity cells as therapeutic eﬀectors	181
A potential role of human RNASET2 overexpression in the pathogenesis of Graves’ disease	181
Recognition of human T Leukaemia virus (HTLV-I) envelope by human CD4+ T cell lines from HTLV-I seronegative individuals: specificity and clonal heterogeneity.	178
The MHC class II transactivator (CIITA): a physiologic inhibitor of HIV1 and HTLV2 retroviral infections	178
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation	178
Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves' disease patients during methimazole treatment	178
Natural killer cells from pleural effusions are responsive to interleukin-2 but are endowed with a potent pro-angiogenic feature	177
Natural killer cells from malignant pleural effusion show a decidual-like phenotype and an alternative activatory state.	175
Tumor rejection and anti-tumor memory to cancer cells of different histotype genetically modified to express CIITA-driven autologous MHC class II genes. A new strategy of anti-tumor vaccination and tumor immunotherapy.	174
Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis	173
Type 1 CD4+ T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptide vaccine in rhesus macaques.	172
Analyse de DC-SIGN dans un modèle de résistance au SIDA	171
Pleural effusion NK cells from metastatic tumors display pro-angiogenic features and pleural effusion fluids block their response to IL-2 treatment	171
TPA-mediated down-regulation of MHC class II gene expression in human macrophage precursors by destabilization of the MHC-II transactivator (CIITA) mRNA	170
A new strategy of tumor vaccination based on mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA	169
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy	166
The human RNASET2 alarmin-like molecule differentially affects prostate cancer cells behavior in both cell autonomous and non-cell autonomous manners	165
Prostate cancer peripheral blood NK cells show enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 production, and secrete monocyte-recruiting and polarizing factors.	165
Plasmocytoid dendritic cell dynamics and alpha IFN production during Simian Immunodeficiency Virus infection with a nonpathogenic outcome	164
Tumor rejection and anti-tumor memory to neoplasias of different histotype genetically modified to express CIITA- autologous MHC class II genes. A new strategy of anti-tumor vaccination and tumor immunotherapy.	164
Analysis of a combined immunodeficiency patient with defect in MHCII expression (BLS) reveals the presence of several mutant isoforms of RFXANK mRNA	164
Natural killer cells infiltrating colo-rectal cancer are switched towards the decidual-like pro-angiogenic CD56brightCD16- NK cell subset	162
Prolonged temporary remission in T1DM patients is associated to a distinctive Treg phenotype	159
CIITA-driven MHC-II+ tumor cells: preventive vaccines and superior generators of anti-tumor CD4+ T lymphocytes for immunotherapy.	158
Down syndrome, autoimmunity and T regulatory cells	158
Overexpression of Murine Rnaset2 in a Colon Syngeneic Mouse Carcinoma Model Leads to Rebalance of Intra-Tumor M1/M2 Macrophage Ratio, Activation of T Cells, Delayed Tumor Growth, and Rejection	158
When a Friend Becomes Your Enemy: Natural Killer Cells in Atherosclerosis and Atherosclerosis-Associated Risk Factors	158
Subcapsular sinus macrophages promote melanoma metastasis to the sentinel lymph nodes via an IL-1α-STAT3 axis	157
Analysis of the selection pressure by the NEF-immunodominant macaque CTL response in SIV infection	157
STAT3 and STAT5 drive the pro-angiogenic NK cell polarization in colorectal cancer patients	157
Antitumor vaccines and immunotherapeutic strategies based on CIITA-driven MHC class II espression in cancer cells.	156
The molecular basis of the inhibition of HTLV-2 retroviral replication by the MHC class II transactivator (CIITA)	156
Early functional activation of natural killer cell and dendritic cell during the antitumor therapeutic response induced by TNFa tumor vessel delivery and melphalan	156
Tumor infiltrating (TINKs) and tumor associated (TANKs) from colorectal cancer patients are proangiogenic and express angiogenin and the MMP9-TIMP2, similar to decidual NK cells	156
The oncosuppressive role of RNASET2 gene in a mouse tumor syngeneic model	155
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: results of a prospective cohort study of 365 patients	155
The history of discovery of Interleukin-1: A fundamental cytokine of the innate immune response	154
Innate immunity driving tumor angiogenesis: the role of natural killer cells in non-small cell lung cancer (NSCLC)	154
The MHC class II transactivator is a strong physiologic antagonist of HIV-1 replication	152
Tumor-infiltrating (TINKs) and tumor-associated (TANKs) natural killer cells: a new player in the inflammatory orchestration of tumor angiogenesis in colon cancer	152
Immune-mediated mechanisms in patients tested positive for SARS-CoV-2: Protocol for a multianalysis study	152
Inflammation, inflammatory cells and angiogenesis: decisions and indecisions	151
CIITA-driven MHC class II expressing tumor cells of distinct hystotype act as a potent antitumor vaccine and as a superior generators of tumor-specific CD4+ T lymphocytes for immunotherapy.	151
Totale	22.169

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	164.062
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	164.062

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	1.675	0	0	0	113	100	56	134	165	213	317	220	357
2022/2023	3.904	335	198	250	412	267	774	60	487	521	189	203	208
2023/2024	7.374	1.081	1.086	1.114	1.210	1.244	513	132	167	213	241	177	196
2024/2025	4.895	146	170	773	314	334	320	185	260	447	474	371	1.101
2025/2026	10.440	682	556	428	1.346	1.117	562	2.307	697	1.073	742	490	440
2026/2027	3.581	335	564	1.479	1.203	0	0	0	0	0	0	0	0
Totale													43.548